Literature DB >> 22088582

[Icariin and its pharmaceutical efficacy: research progress of molecular mechanism].

Yang Chen1, Jian-hua Huang, You Ning, Zi-yin Shen.   

Abstract

Icariin is one of the key active components of Epimedium species, which is most widely applied to supplement the kidney in traditional Chinese medicine. Scientific research has found that icariin possesses extensive therapeutic effects such as protecting neurons from injury, promoting growth of neuronal synapse, improving sexual dysfunction and bone morphogenesis, as well as anti-inflammation, anti-tumor and anti-depression functions. Considering that molecular mechanism is the fundamental basis for pharmaceutical efficacy of icariin, in this article, the authors retrospectively retrieved 122 scientific papers recorded in the PubMed database with "icariin" in the title from January 1, 1995 to January 5, 2011. It was found that icariin has been closely highlighted in the intervention of p38 mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt signal pathways, inhibition of phosphodiesterase 5, and regulation of nuclear receptors. Besides, the authors also discussed the main orientation for molecular mechanism of icariin in future research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22088582     DOI: 10.3736/jcim20111104

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN: 1672-1977


  12 in total

1.  Icariin prevents cytokine-induced β-cell death by inhibiting NF-κB signaling.

Authors:  Shao Zhong; Jing Ge; Jiang-Yi Yu
Journal:  Exp Ther Med       Date:  2018-07-20       Impact factor: 2.447

2.  Effects and mechanisms of icariin on atherosclerosis.

Authors:  Yanwu Hu; Kai Liu; Mengtong Yan; Yang Zhang; Yadi Wang; Liqun Ren
Journal:  Int J Clin Exp Med       Date:  2015-03-15

3.  Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.

Authors:  Dian-cai Zhang; Jin-long Liu; Yong-bin Ding; Jian-guo Xia; Guo-yu Chen
Journal:  Acta Pharmacol Sin       Date:  2012-12-31       Impact factor: 6.150

4.  Icariin Attenuates High-cholesterol Diet Induced Atherosclerosis in Rats by Inhibition of Inflammatory Response and p38 MAPK Signaling Pathway.

Authors:  Yanwu Hu; Bo Sun; Kai Liu; Mengtong Yan; Yang Zhang; Chunsheng Miao; Liqun Ren
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

5.  Genistein exposure inhibits growth and alters steroidogenesis in adult mouse antral follicles.

Authors:  Shreya Patel; Jackye Peretz; Yuan-Xiang Pan; William G Helferich; Jodi A Flaws
Journal:  Toxicol Appl Pharmacol       Date:  2016-01-12       Impact factor: 4.219

6.  Icariin induces synoviolin expression through NFE2L1 to protect neurons from ER stress-induced apoptosis.

Authors:  Fei Li; Beixue Gao; Hongxin Dong; Jingshan Shi; Deyu Fang
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

7.  Active Ingredients of Epimedii Folium and Ligustri Lucidi Fructus Balanced GR/HSP90 to Improve the Sensitivity of Asthmatic Rats to Budesonide.

Authors:  Xiufeng Tang; Xiaoxi Li; Honglei Nian; Yan Yang; Yuheng Chen; Xiujuan Wang; Liping Xu; Xinwei Yang; Renhui Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-11       Impact factor: 2.629

8.  Icariin Inhibits Intestinal Inflammation of DSS-Induced Colitis Mice Through Modulating Intestinal Flora Abundance and Modulating p-p65/p65 Molecule.

Authors:  Haoran Zhang; Shixuan Zhuo; Danni Song; Leyao Wang; Junyi Gu; Junyan Ma; Yang Gu; Minghui Ji; Meijuan Chen; Yuanyuan Guo
Journal:  Turk J Gastroenterol       Date:  2021-04       Impact factor: 1.852

Review 9.  Natural products: a hope for glioblastoma patients.

Authors:  Raghupathy Vengoji; Muzafar A Macha; Surinder K Batra; Nicole A Shonka
Journal:  Oncotarget       Date:  2018-04-24

10.  Icariin Promote Stem Cells Regeneration and Repair Acinar Cells in L-arginine / Radiation -Inducing Chronic Pancreatitis in Rats.

Authors:  Enas M Moustafa; Fatma S M Moawed; Gehan R Abdel-Hamid
Journal:  Dose Response       Date:  2020-10-30       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.